Summit Therapeutics (SMMT) Appoints Jeff Huber to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
June 27, 2024 4:15 PM EDTMIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
It is an honor to add Jeff Huber to our excellent, diverse group of board members, stated Robert W. Duggan, Chairman and Chief Executive Officer of Summit. Jeffs executive leadership experience in healthcare and technology and his countless accomplishments evidence his ability to translate whats possible into transformational success. As we seek to change the standard of care for solid tumors based on the potential of... More



